Sun Pharmaceutical Industries Limited (SPIL)

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03, 2022-04 to 2023-03, 2021-04 to 2022-03, 2020-04 to 2021-03, 2018-19

In its 2023-04 to 2024-03 reporting, Sun Pharmaceutical Industries Limited (SPIL) disclosed greenhouse gas emissions of 111.2K tCO2e (Scope 1) + 237766 tCO2e (Scope 2) = 348941 tCO2e. By scope: Scope 1: 111.2K tCO2e; Scope 2: 237.8K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
111.2K tCO2e (Scope 1) + 237766 tCO2e (Scope 2) = 348941 tCO2e
2023-04 to 2024-03
⚡
Renewable Energy
45.23%
of total energy
💧
Water Usage
1.7M kL
2023-04 to 2024-03
♻️
Waste
39.7K metric tons
2023-04 to 2024-03
⚙️
Energy Use
3.0M GJ
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).111.2K tCO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.237.8K tCO2e

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-04 to 2024-03111.2K tCO2e (Scope 1) + 237766 tCO2e (Scope 2) = 348941 tCO2e
2020-04 to 2021-033.0K tCO2e (Scope 3); 48235 tCO2e (Scope 1); 283928 tCO2e (Scope 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce water consumption by 10% by 2025 (compared to 2020 baseline)
  • Co-process 30% of hazardous waste by 2025

📅 Medium-term

  • Reduce absolute Scope 1 and Scope 2 carbon emissions by 35% by 2030 (compared to 2020 baseline)

🌱 ESG Focus Areas

Climate ChangeWater ManagementWaste ManagementWorkforce Diversity and RetentionCorporate Social ResponsibilityCorporate GovernanceHuman RightsProduct Quality and SafetySupply Chain Sustainability

⚠️ Challenges & Risks +

  • Climate change related physical and transition risks
  • Product quality and safety concerns
  • Cybersecurity and data privacy risks
  • Supply chain disruptions
  • Maintaining high standards of corporate governance and business ethics
  • Ensuring access to and affordability of medicines
  • Occupational health and safety
  • Ethical clinical trials and animal testing

📋 Report Information

Reporting Period: 2023-04 to 2024-03
Frameworks: BRSR Core – Framework for assurance and ESG disclosures for value chain as per SEBI Circular, BRSR reporting guidelines (Annexure II) as per SEBI Circular, Greenhouse Gas Protocol
Assurance: DNV Business Assurance India Private Limited